INTERVIEW: OJ-Bio targets wireless diagnostic sweet spot
This article was originally published in Clinica
Executive Summary
The point-of-care diagnostics market is fairly crowded – but not all would-be players can count a Japanese communications giant among their investors. UK-based OJ-Bio can go one better: the company is a joint venture between two companies, of which Japan Radio Co (JRC) is one of its parent firms.